Femasys Inc (FEMY) stock
FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.12−0.16 (-12.50%)
Close on Nov 17, 2026Market cap $9.38MP/E –Yield –
Femasys operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Femasys's operating cash flow for the twelve months ending Jun 30, 2026 was -$17.65M. For fiscal 2025 it was -$18.69M. The highest annual figure on record is -$4.93M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$18.69M | – |
| FY2024 | Dec 31, 2024 | -$19.44M | – |
| FY2023 | Dec 31, 2023 | -$11.28M | – |
| FY2022 | Dec 31, 2022 | -$10.73M | – |
| FY2021 | Dec 31, 2021 | -$7.93M | – |
| FY2020 | Dec 31, 2020 | -$4.93M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.94M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.14M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.19M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.39M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.35M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.77M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.07M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.47M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.57M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.04M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.86M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.74M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.65M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.87M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.73M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.38M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.75M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.25M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.80M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.72M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.16M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$859.02K | – |
See a number that looks wrong?